Clinical Trials
5
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)โข Click on a phase to view related trials
COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability
- Conditions
- Sars-CoV-2 InfectionCOVID-19
- First Posted Date
- 2022-10-18
- Last Posted Date
- 2023-06-02
- Lead Sponsor
- MP Biomedicals, LLC
- Target Recruit Count
- 99
- Registration Number
- NCT05584189
- Locations
- ๐บ๐ธ
EDP Biotech Corporation, Knoxville, Tennessee, United States
COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation
- Conditions
- COVID-19SARS-CoV2 Infection
- First Posted Date
- 2022-10-18
- Last Posted Date
- 2023-06-01
- Lead Sponsor
- MP Biomedicals, LLC
- Target Recruit Count
- 332
- Registration Number
- NCT05584176
- Locations
- ๐บ๐ธ
Accel Research, DeLand, Florida, United States
๐บ๐ธDaniel Sarkis, Gainesville, Florida, United States
๐บ๐ธAccel Research Site St. Petersburg, Saint Petersburg, Florida, United States
MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study
- Conditions
- HTLV I Associated T Cell Leukemia LymphomaHTLV-I InfectionsHuman T-lymphotropic Virus 1HTLV I Associated MyelopathiesHuman T-lymphotropic Virus 2HTLV-II Infections
- First Posted Date
- 2017-07-21
- Last Posted Date
- 2018-09-13
- Lead Sponsor
- MP Biomedicals, LLC
- Target Recruit Count
- 150
- Registration Number
- NCT03226119
- Locations
- ๐บ๐ธ
LABS, Inc., Philadelphia, Pennsylvania, United States
๐บ๐ธQualtex Laboratories, San Antonio, Texas, United States
๐บ๐ธEastern Virginia Medical School (EVMS), Norfolk, Virginia, United States
Dual Algorithm Post Market Clinical Study
- Conditions
- Human T-lymphotropic Virus 2Human T-lymphotropic Virus 1HTLV I Associated T Cell Leukemia LymphomaHTLV-I InfectionsHTLV-II InfectionsHTLV I Associated Myelopathies
- First Posted Date
- 2017-05-09
- Last Posted Date
- 2017-06-12
- Lead Sponsor
- MP Biomedicals, LLC
- Target Recruit Count
- 100
- Registration Number
- NCT03146013
- Locations
- ๐บ๐ธ
American Red Cross - National Testing Laboratory, Charlotte, North Carolina, United States
Evaluation of the MP Diagnostics HTLV Blot 2.4
- Conditions
- HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1Human T-lymphotropic Virus 2HTLV I Associated T Cell Leukemia LymphomaHTLV I Associated Myelopathies
- First Posted Date
- 2011-11-08
- Last Posted Date
- 2011-11-08
- Lead Sponsor
- MP Biomedicals, LLC
- Target Recruit Count
- 600
- Registration Number
- NCT01467024
- Locations
- ๐บ๐ธ
California Department of Public Health, Richmond, California, United States
๐บ๐ธLABS, Inc, St. Louis, Missouri, United States